Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment
The Effects of Supplemental Postoperative 0.5% Bupivacaine With 1:200,000 Epinephrine Following Non-Surgical Endodontic Treatment on Patients' Quality of Life, Pain, and Analgesic Consumption
Sponsor: New York University
Listed as NCT06655454, this PHASE2 trial focuses on Analgesic Use and Pain Assessment and remains actively recruiting participants. Sponsored by New York University, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Jun 2025 — Present [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Nov 2024 — Jun 2025 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- New York University
For direct contact, visit the study record on ClinicalTrials.gov .